Summary:
The effects of Acthar on synovial inflammation in Rheumatoid Arthritis: A pilot study.
Qualified Participants Must:
• Diagnosed with CCP positive
•
Rheumatoid Arthritits Stable dose regimen of Medications
•
Moderate to Severe Disease Activity
Qualified Participants May Receive:
Treatment with FDA approved medication Either Acthar or Depo-Medrol